![Ebun Garner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ebun Garner
Consigliere Generale presso
ERASCA, INC.
Patrimonio netto: 455 129 $ in data 31/07/2026
Profilo
Ebun S.
Garner currently works at Erasca, Inc., as Secretary & General Counsel from 2021.
Mr. Garner also formerly worked at Scient'x SA, as Director General, Neurocrine Biosciences, Inc., as Associate General Counsel from 2017 to 2019, ACADIA Pharmaceuticals, Inc., as Assistant General Counsel from 2020 to 2021, Alphatec Holdings, Inc., as Secretary, Senior Vice President & General Counsel from 2011 to 2017, Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC, as Associate from 2000 to 2005, Squadron, Ellenoff, Plesent & Sheinfeld LLP, as Associate from 1999 to 2000, Alphatec Spine, Inc., as Secretary, Senior Vice President & General Counsel from 2011 to 2017, and Imbria Pharmaceuticals, Inc., as Secretary & Chief Legal Officer from 2019 to 2020.
Mr. Garner received his undergraduate degree from the University of Pennsylvania and graduate degree from New York University School of Law.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ERASCA, INC. 0,01% | 01/04/2026 | 25.076 ( 0,01% ) | 455 129 $ | 31/07/2026 |
Posizioni attive di Ebun Garner
| Società | Posizione | Inizio |
|---|---|---|
| ERASCA, INC. | Consigliere Generale | 01/04/2021 |
Precedenti posizioni note di Ebun Garner
| Società | Posizione | Fine |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/04/2021 |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Consigliere Generale | 01/07/2020 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/04/2019 |
| ALPHATEC HOLDINGS, INC. | Contatto Relazioni con gli Investitori | 23/07/2012 |
Alphatec Spine, Inc.
 Alphatec Spine, Inc. Medical SpecialtiesHealth Technology Designs, manufactures, and sells medical devices for surgical treatment of spine disorders | Consigliere Generale | 28/02/2017 |
Formazione di Ebun Garner
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
54
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Alphatec Holdings, Inc.
 Alphatec Holdings, Inc. Medical SpecialtiesHealth Technology Operates as a holding company with interests in medical equipment and supplies | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Squadron, Ellenoff, Plesent & Sheinfeld LLP
 Squadron, Ellenoff, Plesent & Sheinfeld LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Scient'x SA
 Scient'x SA Medical SpecialtiesHealth Technology Designs, develops and markets spinal implant devices for the lumbar, thoracic and cervical spine | Health Technology |
Alphatec Spine, Inc.
Alphatec Spine, Inc. Medical SpecialtiesHealth Technology Designs, manufactures, and sells medical devices for surgical treatment of spine disorders | Health Technology |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
